NKTR: Nektar Sotuvga nisbatan narx

Nektar Corp (NKTR) kompaniyasining korporativ logotipi

Nektar Therapeutics (NKTR) kompaniyasining narx/savdo koeffitsienti shtatlar sonini keskin qisqartirish va autoimmun patologiyalarni davolashga qaratilgan strategik yo'nalishning oqibatlarini aks ettiradi. Ushbu ko'rsatkich 24.40 darajasida bo'lib, dori vositalarini ishlab chiqishni tezlashtirish uchun AI skriningini joriy etish sharoitida baholashni talab qiladi. Biroq, mablag'larning yuqori sarf tezligi va klinik sinovlarning muvaffaqiyatsiz tugash xavflari joriy yon tomonga yo'naltirilgan diapazon ichidagi kotirovkalarning barqarorligiga tahdid solmoqda.

NKTR (Nektar) P/S multiplikatori tarixi 04.07.2022dan 15.11.2026gacha

Nektar (NKTR) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

Kompaniyaning umumiy tahlili:NKTR Nektar Therapeutics Inc
Nektar Therapeutics Inc brend mahsuloti

Muvaffaqiyatsiz sinovlardan so'ng Nektar Therapeutics (NKTR) himoya patentlariga bo'lgan ishonchning pasayishi bozorni kelgusi daromadlar qiymatini qayta baholashga majbur qilmoqda. Narx-sotuvlar grafikasi tahlili orqali investor sotuvlarning bir dollarlik kapitalizatsiya ko'rsatkichini ko'rishi mumkin, bu esa aktivning premiumini aniqlash imkonini beradi va aksiyalarni baholash diapazonining cho'qqisida sotib olish orqali kapitalning muzlab qolishining oldini olishga yordam beradi.

Nektar Therapeutics raqobatchilari

argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols Biemat) - P/S multiplikatori|P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning daromadga nisbati Celldex Therapeutics (CLDX)|Narx/daromad koeffitsiyenti auriniapharma.com|Narxning daromadga nisbati BioCryst Pharmaceuticals BCRX|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Pharma - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL: P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati Intrexon|PHAR - Narx/daromad multiplikatori|P/S multiplikatori UPB|ZBIO - Sotuvga nisbatan narx|P/S multiplikatori IMNM (immunome.com)|Gossamer Bio, Inc. - Narxning daromadga nisbati|KalVista Pharmaceuticals, Inc. - P/S multiplikatori|SEPN (Septerna) - Kapitalizatsiya va daromad nisbati|Pieris Corp (PVLA) - Narxning daromadga nisbati|SVRA - Narx/daromad koeffitsiyenti|RIGL (rigel.com) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANAB (AnaptysBio, Inc.)|P/S multiplikatori ATXS|enGene Holdings Inc (ENGN) - Narx/daromad multiplikatori|P/S multiplikatori RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Narxning sotuvga nisbati|ACRS: Kapitalizatsiyaning daromadga nisbati|KYTX - P/S multiplikatori|TLSA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Cabaletta Bio, Inc|Narxning daromadga nisbati Ventyx Biosciences, Inc|THTX: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati AVTX (Avalo Therapeutics, Inc)|Kapitalizatsiyaning daromadga nisbati Eledon Pharmaceuticals ELDN|Narxning daromadga nisbati Agenus, Inc. AGEN|P/S multiplikatori Climb Bio Inc. CLYM|ZURA - Narxning daromadga nisbati|Narxning sotuvga nisbati ATYR|ADAG (Adagene Inc.) - Kapitalizatsiyaning daromadga nisbati|ImageneBio Inc (IMA) - P/S multiplikatori|Narxning daromadga nisbati Shattuck Therapeutics|Kapitalizatsiyaning daromadga nisbati equilliumbio.com (EQ)|P/S multiplikatori CNTB|Narx/daromad koeffitsiyenti Immunic Therapeutics|P/S multiplikatori ATRA (Atara Biotherapeutics, Inc.)|IFRX - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Kapitalizatsiya va daromad nisbati|CELU: P/S multiplikatori|INMB - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Barinthus Biotherapeutics plc|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|AKTX (Akari Therapeutics Plc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Narxning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|edesabiotech.com (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|CARM - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiyaning daromadga nisbati boltbio.com (BOLT)|Narxning daromadga nisbati HCW Biologics Inc (HCWB)|P/S multiplikatori Aptevo Therapeutics, Inc. (APVO)|Narxning daromadga nisbati aimimmuno.com AIM|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio Corporation - P/S multiplikatori|XORTX Corp (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (Vyome Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori